The global airway clearance systems market size is expected to reach USD 698.11 million by 2026, registering a CAGR of 4.5% over the forecast period, according to a new report by Grand View Research, Inc. The airway or mucus clearance devices are majorly used for the treatment of various respiratory diseases. Rising adoption of clearance system to curb the surmounting prevalence of cystic fibrosis, Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis is the primary market driver.
According to the U.S. Department of Health and Human Services, About 1 in every 2,500 to 3,500 Caucasian babies is diagnosed with cystic fibrosis in U.S. This ratio significantly lower among Asian and African Americans at 1 in 31,000 and 17,000 births, respectively. This factor is expected to contribute to the product demand over the forecast period.
Breakthroughs in airway clearance systems are anticipated to positively influence the market. For instance, as manufactured by Dymedso, a digitally controlled acoustic airway clearance device endorses bronchial drainage by inducing vibration in the thoracic walls. Leading to a less painful and more effective treatment. Groundbreaking technological advancements are rapidly transforming the airway clearance devices, creating new growth opportunities.
Request a sample Copy of the Global Airway Clearance Systems Market Research Report @ https://www.grandviewresearch.com/industry-analysis/airway-clearance-systems-market
Key players operating in the airway clearance systems market are Hill-Rom Holdings, Inc.; Electromed Inc.; Aptalis Pharma U.S. Inc.; and Thayer Medical. These players account for a significant market share, owing to their broad product offerings. Microsoft, Great Ormond Street Hospital, and University College London have collaborated to develop Project Fizzyo, to make the cystic fibrosis treatment more enjoyable for the children. This project gamifies the treatment with the help of innovative technology.
Major market players are focusing on increasing their brand penetration and acceptance by collaborating with insurance companies. For instance, under Patient Assistance Program, Hill-Rom offers access to VitalCough System and Vest Airway Clearance System for reducing the financial burden from the eligible patients.
Key suggestions from the report:
- Flutter mucus clearance device held the dominant market share in 2018 due to cost effectiveness, ease of use, and easy portability of the product
- Cystic fibrosis segment held the largest market share in 2018 and is anticipated to witness significant CAGR over the forecast period due to growing patient population and available of patient care support
- Home care settings held the dominant market share in 2018 mainly due to ease of therapy accessed from the comfort of home
- Hill-Rom Holdings, Inc.; Electromed Inc.; Aptalis Pharma U.S. Inc.; and Thayer Medical are some of the major market player
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/6809/ibb
Grand View Research has segmented the global airway clearance systems market on the basis of the device type, application, end use, and region:
Airway Clearance Systems Device Type Outlook (Revenue, USD Million, 2014 – 2026)
- Positive Expiratory Pressure (PEP)
- Flutter Mucus Clearance Device
- High Frequency Chest Wall Oscillation (HFCWO)
- Intrapulmonary Percussive Ventilation (IPV)
Airway Clearance Systems Application Outlook (Revenue, USD Million, 2014 – 2026)
- Cystic Fibrosis
- Others (Immotile Cilia Syndrome, Chronic Bronchitis)
Airway Clearance Systems End Use Outlook (Revenue, USD Million, 2014 – 2026)
- Hospitals & Clinics
- Home Care Settings
- Ambulatory Surgical Centers
Airway Clearance Systems Regional Outlook (Revenue, USD Million, 2014 – 2026)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
Find more research reports on Medical Devices Industry, by Grand View Research:
Connected Drug Delivery Devices Market – The global connected drug delivery devices market size was valued at USD 138.9 million in 2017.
Clinical Trial Imaging Market – The global clinical trial imaging market size was valued at USD 790.5 million in 2017.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
For more information: www.grandviewresearch.com
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States